The process of Alzheimer's disease (AD), the most common form of dementia, is thought to begin years before symptoms. This preclinical phase, characterized by abnormal levels of brain amyloid accumulation consistent with AD, holds the key to identifying causes and developing therapeutic strategies. In the absence of sensitive and specific behavioral/cognitive tests, quantitative biomarkers and genetic tests will be critical for stratified medicine in preclinical AD. This project will examine two high-dimensional data modalities, namely structural brain MRI scans and genome-wide SNP data, in order to derive tools to compute individual-level predictions about future dementia onset. AD imprints a unique atrophy signature on the brain discernable in structural MRI scans. Converging data suggest that AD-associated atrophy is detectable years before clinical symptoms. The machine learning (or pattern analysis) approach, which our laboratory has advocated in neuroimage analysis, offers highly sensitive and specific atrophy detectors. We hypothesize these tools will be invaluable for identifying preclinical AD subjects who are at increased risk of dementia onset. Late-onset AD (LOAD), which represents >95% of all AD cases, is up to 70% heritable. In addition to APOE4, the major genetic risk factor, recent genome-wide association studies (GWAS) have identified a growing list of other common genetic variants associated with LOAD. The complexity of LOAD's genetic underpinnings suggests that sophisticated models that aggregate data across the genome might help us explain some of the variability in disease progression. Developing such models using state-of-the-art machine learning technology and leveraging already-collected large-scale datasets is one of our main aims in this proposal. The proposed project will build on the principal investigator's (Sabuncu) strong background in computational modeling and machine learning to conduct analyses using cutting-edge methods on large-scale data. We will use multi-modal data, including neuroimaging and GWAS data, to develop and validate models that predict future decline in preclinical LOAD. Our method of choice will be a novel Bayesian ML algorithm, specifically designed for longitudinal data. We hypothesize that the developed models will be more useful than alternatives (constructed by discriminating cases and controls) for identifying amyloid positive individuals who are at heightened risk of imminent clinical decline. We will use a multi-level approach for discovery and validation and a multi-modal strategy to test our hypothesis.

Public Health Relevance

Thanks to recent technological advances we can now reliably detect Alzheimer's pathology in individuals during the preclinical phase, which can last years before symptoms begin. Yet we lack the tools to predict the course of these preclinical individuals, many of which progress to dementia quite quickly, while others remain asymptomatic. The proposed project will leverage large- scale datasets such as the Alzheimer's Disease Neuroimaging Initiative (ADNI) and sophisticated data mining techniques to derive models that can predict future clinical decline based on multi-modal data, including genetic markers and MRI scans.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Exploratory/Developmental Grants (R21)
Project #
1R21AG050122-01A1
Application #
9033273
Study Section
Special Emphasis Panel (ZRG1)
Program Officer
Anderson, Dallas
Project Start
2016-05-01
Project End
2018-04-30
Budget Start
2016-05-01
Budget End
2017-04-30
Support Year
1
Fiscal Year
2016
Total Cost
Indirect Cost
Name
Massachusetts General Hospital
Department
Type
DUNS #
073130411
City
Boston
State
MA
Country
United States
Zip Code
Ge, Tian; Holmes, Avram J; Buckner, Randy L et al. (2017) Heritability analysis with repeat measurements and its application to resting-state functional connectivity. Proc Natl Acad Sci U S A 114:5521-5526
Dalca, Adrian V; Bouman, Katherine L; Freeman, William T et al. (2017) Population Based Image Imputation. Inf Process Med Imaging 10265:659-671
Nenning, Karl-Heinz; Liu, Hesheng; Ghosh, Satrajit S et al. (2017) Diffeomorphic functional brain surface alignment: Functional demons. Neuroimage 156:456-465
Sabuncu, Mert R; Ge, Tian; Holmes, Avram J et al. (2016) Morphometricity as a measure of the neuroanatomical signature of a trait. Proc Natl Acad Sci U S A 113:E5749-56
Mormino, Elizabeth C; Sperling, Reisa A; Holmes, Avram J et al. (2016) Polygenic risk of Alzheimer disease is associated with early- and late-life processes. Neurology 87:481-8
Ge, Tian; Reuter, Martin; Winkler, Anderson M et al. (2016) Multidimensional heritability analysis of neuroanatomical shape. Nat Commun 7:13291
Langs, Georg; Wang, Danhong; Golland, Polina et al. (2016) Identifying Shared Brain Networks in Individuals by Decoupling Functional and Anatomical Variability. Cereb Cortex 26:4004-14
Zhang, Xiuming; Mormino, Elizabeth C; Sun, Nanbo et al. (2016) Bayesian model reveals latent atrophy factors with dissociable cognitive trajectories in Alzheimer's disease. Proc Natl Acad Sci U S A 113:E6535-E6544